Abstract Introduction: This study aimed to review the surgical excision results and pathological diagnostic features of rarely observed intracardiac masses in the light of the literature. Diagnosis and treatment approaches and complications were evaluated. Methods: Forty patients (26 females, mean age 52.1±18.1 years, and 14 males, mean age 48.1±20.5 years), who had undergone surgery for intracardiac mass between January 2008 and December 2018, were included in this study. The patients’ data were analyzed retrospectively from the medical records of both centers. Results: When the pathological diagnoses were examined, 85.8% of the masses (n=35) were observed to be benign (benign tumor + hydatid cyst) and 14.2% (n=5) were malignant tumors. The masses were most commonly located in the left atrium (75%, n=30), and this was followed by the right ventricle (12.5%, n=5), right atrium (7.5%, n=3), and left ventricle (5%, n=2). Of the patients, 7.5% (n=3) died during the early postoperative period, while the remaining 92.5% (n=37) were discharged with healing. In the histopathological diagnosis of the patients, in whom in-hospital major adverse cardiovascular events were observed, there was malignancy in two cases. Conclusion: Intracardiac masses, which have pathological features, are severe life-threatening problems. In-hospital mortality is frequent, especially in malignant tumors. Introduction literature evaluated Methods 26 (2 females 521181 52 1 18 52.1±18. years males 481205 48 20 5 48.1±20. , years) 200 2018 centers Results examined 858 85 8 85.8 n=35 n35 n 35 (n=35 cyst 142 2 14.2 n=5 n5 (n=5 tumors 75%, 75 (75% n=30, n30 n=30 30 n=30) 12.5%, 125 12 (12.5% n=5, n=5) 7.5%, 7 (7.5% n=3, n3 n=3 3 n=3) 5%, (5% n=2. n2 n=2 . n=2) 7.5 (n=3 period 925 92 92.5 n=37 n37 37 (n=37 healing inhospital hospital cases Conclusion lifethreatening life threatening problems Inhospital frequent ( 52118 52.1±18 48120 4 48.1±20 201 85. 14. n= (n= 75% (75 12.5% (12.5 (7.5 5% (5 7. 9 92. 5211 52.1±1 4812 48.1±2 (n (7 12.5 (12. (7. 521 52.1± 481 48.1± 12. (12 52.1 48.1 (1 52. 48.

Resumo Justificativa e objetivos: O bloqueio do plano transverso abdominal é um método de bloqueio periférico que tem sido usado com sucesso para alívio da dor após histerectomia abdominal total. No entanto, os efeitos da combinação do bloqueio do plano transverso abdominal e da anestesia geral sobre a necessidade de analgésico e anestésico ainda não estão claros. Este estudo randômico e controlado com placebo tem como objetivo avaliar os efeitos do bloqueio do plano transverso abdominal sobre o consumo de analgésico e anestésico durante histerectomia abdominal total sob anestesia geral. Métodos: Foram randomizadas em dois grupos 66 mulheres submetidas à histerectomia abdominal total para receber apenas anestesia geral (grupo controle) ou associada a bloqueio do plano transverso abdominal com 20 mL de bupivacaína a 0,25% (grupo plano transverso abdominal). O consumo de remifentanil e sevoflurano no período intraoperatório foi registrado. Também avaliamos a dor pós-cirurgia, náusea, qualidade dos escores de recuperação e necessidade de analgésico de resgate durante as 24 horas de pós-operatório. Resultados: O consumo total de remifentanil e sevoflurano foi significativamente menor no grupo plano transverso abdominal, respectivamente, média (DP): 0,130 (0,25) vs. 0,094 (0,02) mcg.kg-1.min-1; p < 0,01 e 0,295 (0,05) vs. 0,243 (0,06) mL.min-1; p < 0,01. No pós-operatório, os escores de dor foram significativamente reduzidos no grupo plano transverso abdominal logo após a cirurgia; mediana (intervalo): 6 (2-10) vs. 3 (0-5); p < 0,001, em 2 h (5 [3-9] vs. 2,5 [0-6]; p < 0,001), em 6 h (4 [2-7] vs. 3 [0-6], p < 0,001), em 12 h (3,5 [1-6] vs. 2 [1-5]; p = 0,003). As pacientes do grupo plano transverso abdominal apresentaram escores QoR-40 significativamente maiores: 190,5 (175-197) vs. 176,5 (141-187); p < 0,001). Conclusão: A combinação de bloqueio do plano transverso abdominal e anestesia geral pode proporcionar um consumo reduzido de opioides e anestésicos e melhorar a dor pós-cirúrgica e a qualidade dos escores de recuperação em pacientes submetidas à histerectomia abdominal total.

Abstract Background and objectives: A transversus abdominis plane block is a peripheral block method that has been used successfully for pain relief after total abdominal hysterectomy. However, the effects of the combination of the transversus abdominis plane block and general anesthesia on analgesic and anesthetic requirements remain unclear. This randomized placebo-controlled study is aimed to evaluate the effects of transversus abdominis plane block on analgesic and anesthetic consumption during total abdominal hysterectomy under general anesthesia. Methods: Sixty-six women undergoing total abdominal hysterectomy were randomized into two groups to receive general anesthesia alone (control group) or with transversus abdominis plane block using 20 mL of 0.25% bupivacaine (transversus abdominis plane group). Intraoperative remifentanil and sevoflurane consumption were recorded. We also evaluated the postoperative pain, nausea, quality of recovery scores and rescue analgesic requirement during postoperative 24 hours. Results: The total remifentanil and sevoflurane consumption is significantly lower in transversus abdominis plane group; respectively mean (SD) 0.130 (0.25) vs. 0.094 (0.02) mcg.kg-1.min-1; p < 0.01 and 0.295 (0.05) vs. 0.243 (0.06) mL.min-1; p < 0.01. In the postoperative period, pain scores were significantly reduced in transversus abdominis plane group soon after surgery; median (range) 6 (2-10) vs. 3 (0-5); p < 0.001, at 2 h (5 [3-9] vs. 2.5 [0-6]; p < 0.001), at 6 h (4 [2-7] vs. 3[0-6], p < 0.001), at 12 h (3.5 [1-6] vs. 2 [1-5]; p = 0.003). The patients in the transversus abdominis plane group had significantly higher QoR-40 scores 190.5 (175-197) vs. 176.5 (141-187); p < 0.001). Conclusion: Combining transversus abdominis plane block with general anesthesia can provide reduced opioid and anesthetic consumption and can improve postoperative pain and quality of recovery scores in patients undergoing total abdominal hysterectomy.

Background: Liver biopsy, which is considered the best method for evaluating hepatic fibrosis, has important adverse events. Therefore, non-invasive tests have been developed to determine the degree of hepatic fibrosis in patients with chronic hepatitis B. Aim: To verify the usefulness of a new fibrosis index the globulin/platelet model in patients with chronic hepatitis B and to compare it with other noninvasive tests for predicting significant fibrosis. This study was the second to evaluate the globulin/platelet model in HBV patients. Methods: We retrospectively investigated 228 patients with chronic hepatitis B who performed liver biopsy from 2013 to 2014. The globulin/platelet model, APGA [AST/Platelet/Gamma-glutamyl transpeptidase/Alfa-fetoprotein], FIB4, fibrosis index, cirrhosis discriminate score, and Fibro-quotient were calculated, and the diagnostic accuracies of all of the fibrosis indices were compared between the F0-2 (no-mild fibrosis) and F3-6 (significant fibrosis) groups. Results: All of the noninvasive markers were significantly correlated with the stage of liver fibrosis (p < 0,001). To predict significant fibrosis (F ≥ 3), the area under the curve (95% CI) was found to be greatest for APGA (0.83 [0.74-0.86]), followed by FIB-4 (0.75[0.69-0.80]), the globulin/platelet model (0.74 [0.68-0.79]), fibrosis index (0.72 [0.6-0.78], cirrhosis discriminate score (0.71 [0.64-0.76]) and Fibro-quotient (0.62 [0.55-0.7]). The area under the receiver operating characteristic curves of APGA was significantly higher than that of the other noninvasive fibrosis markers (p < 0.05). Conclusions: While the APGA index was found to be the most valuable test for the prediction significant fibrosis in patients with chronic hepatitis B, GP model was the thirth valuable test. Therefore, we recommended that APGA could be used instead of the GP model for prediction liver fibrosis.